The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "Patent Eligibility in the Life Sciences: Exergen and Praxair - and USPTO Memos on Vanda and Berkheimer" on June 14, 2018 from 2:00 to 3:00 pm (ET). Paul Golian of Bristol-Myers Squibb Company, Ali Salimi of the U.S. Patent & Trademark Office, and Warren Woessner of Schwegman, Lundberg & Woessner, P.A. will assess the cumulative impact of recent changes on patent eligibility and delineate prosecution strategies to address them.
The registration fee for the webinar is $135 (government and academic rates are available upon request). Those interested in registering for the webinar can do so here.